Impact of suppressing ciprofloxacin susceptibility results on antibiotic utilization and hospital-acquired Clostridioides difficile infection
Main Authors: | Bryan P. White, Daniel B. Chastain, Karen K. Kinney, Katie Thompson, Jerry Kelley, Cindy B. McCloskey |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2021-01-01
|
Series: | Antimicrobial Stewardship & Healthcare Epidemiology |
Online Access: | https://www.cambridge.org/core/product/identifier/S2732494X21001789/type/journal_article |
Similar Items
-
Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action
by: Andrew T. Dysangco, et al.
Published: (2022-01-01) -
Characterization of community-acquired Clostridioides difficile strains in Israel, 2020–2022
by: Orna Schwartz, et al.
Published: (2023-12-01) -
Antibiotic resistance and genomic features of Clostridioides difficile in southwest China
by: Wenpeng Gu, et al.
Published: (2022-09-01) -
Host-defense piscidin peptides as antibiotic adjuvants against Clostridioides difficile
by: Adenrele Oludiran, et al.
Published: (2024-01-01) -
Host-defense piscidin peptides as antibiotic adjuvants against Clostridioides difficile.
by: Adenrele Oludiran, et al.
Published: (2024-01-01)